The Care and Cure of the Leukemias in 2026 - PubMed
5 hours ago
- #immunotherapy
- #leukemia
- #targeted therapy
- Development of novel targeted therapies and advances in genomics have transformed leukemia treatment.
- Immunotherapies, TKIs, BCL-2 inhibitors, and CAR T-cell therapies have significantly improved survival rates.
- Philadelphia-positive ALL and CLL, once incurable, now have high 5- and 10-year survival rates.
- BCR::ABL1 TKIs have enabled normal life expectancy in chronic myeloid leukemia.
- Targeted therapies have advanced AML treatment, though some subsets still face poor outcomes.
- The optimistic view is that most, if not all, leukemias are curable with current and emerging therapies.